🇺🇸 FDA
Patent

US 11939591

Genetically modified MSC and therapeutic methods

granted A61KA61K48/005

Quick answer

US patent 11939591 (Genetically modified MSC and therapeutic methods) held by The Regents of the University of California expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K48/005